2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Ascites Hepatic: new trials by email Literature Review of Ascites Hepatic trials Research Report on Ascites Hepatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics PHIN-214 Subcutaneous injection - Cirrhosis, Liver, Liver Fibrosis | Phase 1 | Recruiting | PharmaIN | 74 | 2022-01-03 | 2025-09-05 |
| Empagliflozin in Diuretic Refractory Ascites Empagliflozin 10 MG - Liver Cirrhosis, Cirrhosis | Phase 1 | Completed | Stanford University | 14 | 2021-11-15 | 2023-08-02 |
| A Study of OsrHSA in Adult Healthy Male and Female Volunteers OsrHSA 20 mg/kg IV, OsrHSA 40 mg/kg IV, OsrHSA 80 mg/kg IV - Ascites Hepatic | Phase 1 | Completed | Healthgen Biotechnology Corp. | 41 | 2019-11-04 | 2021-06-01 |
Ascites (2) · Fibrosis (2) · Liver Cirrhosis (2)
Digestive System Diseases (2) · Liver Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
empagliflozin (1)
Healthgen Biotechnology Corp. (1) · PharmaIN (1) · Stanford University (1)
United States (3)
Aparna Goel, MD (1) · Cynthia C Jones (1) · David Nguyen, MD, MBA (1)